Profile data is unavailable for this security.
About the company
ReproCELL Incorporated is primarily engaged in the development of stem cell technologies. The Company operates its business in two segments. The IPS Cell segment deals with regenerative medicine focused on Human ES (embryonic stem) cells and human iPS (induced pluripotent stem) cells. This segment manufactures research reagents used in human ES / iPS cell research, such as culture fluid, peeling liquid, frozen preservation solution, coating agents and antibody. The Clinical Testing segment clinical testing services that is required by hematopoietic stem cell transplantation and organ transplantation.
- Revenue in JPY (TTM)2.49bn
- Net income in JPY-178.74m
- Incorporated2003
- Employees96.00
- LocationReproCell Inc9F, KDX Shin-Yokohama 381 Bldg.3-8-11, Shin-Yokohama, Kohoku-kuYOKOHAMA-SHI 222-0033JapanJPN
- Phone+81 454753887
- Fax+81 454741006
- Websitehttps://reprocell.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Delta-Fly Pharma Inc | 0.00 | -1.65bn | 6.11bn | 13.00 | -- | 7.62 | -- | -- | -214.95 | -214.95 | 0.00 | 89.00 | 0.00 | -- | -- | 0.00 | -204.19 | -67.70 | -226.67 | -72.02 | -- | -- | -- | -877.69 | -- | -406.70 | 0.00 | -- | -- | -- | -7.57 | -- | -9.04 | -- |
| NIPPON CHEMIPHAR CO., LTD. | 31.54bn | -255.00m | 6.38bn | 887.00 | -- | 0.2912 | 5.66 | 0.2023 | -70.67 | -70.67 | 8,739.80 | 5,141.74 | 0.613 | 2.04 | 2.95 | 35,554,680.00 | -0.4976 | 0.7482 | -0.6958 | 1.08 | 26.07 | 30.99 | -0.8117 | 1.13 | 1.52 | -0.7018 | 0.5041 | 50.73 | -2.57 | -2.10 | -153.10 | -- | 24.62 | -12.94 |
| COSMO BIO COMPANY, LIMITED | 9.87bn | 367.00m | 7.05bn | 155.00 | 18.54 | 0.7611 | 13.54 | 0.7143 | 62.89 | 62.89 | 1,691.08 | 1,531.97 | 0.8932 | 5.95 | 3.96 | 63,690,320.00 | 3.49 | 5.62 | 4.06 | 6.72 | 32.98 | 37.40 | 3.91 | 6.23 | 6.67 | -- | 0.0021 | 33.53 | -2.23 | 5.16 | -14.51 | 11.20 | -8.03 | 16.47 |
| Wakamoto Pharmaceutical Co Ltd | 7.93bn | 190.01m | 8.29bn | 274.00 | 43.47 | 0.6914 | 13.63 | 1.05 | 5.47 | 5.47 | 228.52 | 344.22 | 0.5106 | 2.00 | 3.29 | 28,945,390.00 | 1.22 | -2.28 | 1.39 | -2.64 | 47.52 | 51.00 | 2.40 | -3.97 | 3.48 | -- | 0.0083 | -- | -10.65 | -6.35 | -21.19 | -- | 4.93 | -- |
| K Pharma Inc | 0.00 | -680.95m | 8.47bn | 15.00 | -- | 3.16 | -- | -- | -58.58 | -58.58 | 0.00 | 230.79 | 0.00 | 0.00 | -- | 0.00 | -27.16 | -- | -29.66 | -- | -- | -- | -- | -- | 34.85 | -- | 0.00 | -- | -- | -- | 166.34 | -- | -- | -- |
| Kohjin Bio Co Ltd | -100.00bn | -100.00bn | 9.25bn | 159.00 | -- | 1.80 | -- | -- | -- | -- | -- | 1,003.21 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.82 | -- | 0.2942 | -- | 0.5715 | -- | -53.61 | -- | -- | -- |
| Perseus Proteomics Inc | 96.49m | -901.50m | 9.46bn | 25.00 | -- | 4.79 | -- | 98.08 | -74.89 | -74.89 | 8.00 | 134.05 | 0.0443 | 3.21 | 11.84 | 3,859,520.00 | -41.36 | -41.34 | -43.27 | -43.43 | 87.73 | 91.72 | -934.32 | -891.26 | 19.91 | -- | 0.00 | -- | 6.58 | -18.31 | -40.34 | -- | 60.30 | -- |
| Solasia Pharma KK | 159.00m | -1.29bn | 9.82bn | 24.00 | -- | 4.57 | -- | 61.75 | -7.36 | -7.36 | 0.9065 | 9.85 | 0.0639 | 0.8549 | 0.5256 | 6,625,000.00 | -51.68 | -48.57 | -59.50 | -58.83 | 31.45 | 71.01 | -808.81 | -300.89 | 3.42 | -61.24 | 0.0219 | -- | -43.50 | 14.18 | 56.36 | -- | -- | -- |
| ReproCell Inc | 2.49bn | -178.74m | 10.00bn | 96.00 | -- | 1.13 | -- | 4.02 | -2.03 | -2.03 | 28.72 | 93.57 | 0.2826 | 4.76 | 6.63 | 25,940,160.00 | -2.03 | -7.35 | -2.20 | -8.00 | 48.99 | 39.83 | -7.18 | -27.16 | 9.99 | -- | 0.00 | -- | -17.83 | 17.39 | 89.71 | -- | 13.27 | -- |
| RaQualia Pharma Inc | 2.30bn | -673.00m | 10.56bn | 67.00 | -- | 1.87 | -- | 4.59 | -31.12 | -31.12 | 106.28 | 261.02 | 0.2652 | 3.82 | 2.89 | 34,300,980.00 | -7.77 | 2.13 | -8.56 | 2.26 | 84.78 | 88.49 | -29.28 | 5.32 | 3.55 | -- | 0.3972 | 0.00 | -34.85 | 20.62 | -144.74 | -- | 0.0967 | -- |
| Symbio Pharmaceuticals Ltd | 3.07bn | -4.02bn | 11.02bn | 109.00 | -- | 2.13 | -- | 3.59 | -92.13 | -92.13 | 70.03 | 112.55 | 0.4225 | 2.97 | 4.47 | 28,137,370.00 | -55.36 | -19.18 | -62.58 | -23.62 | 77.57 | 65.84 | -131.05 | -24.32 | 6.51 | -- | 0.00 | -- | -44.15 | 7.82 | -266.45 | -- | 42.39 | -- |
| Ohki Healthcare Holdings Co Ltd | 254.49bn | 1.28bn | 11.72bn | 632.00 | 8.93 | 0.3805 | 7.74 | 0.0461 | 93.26 | 93.26 | 18,553.59 | 2,189.15 | 1.82 | 9.59 | 3.36 | 402,672,500.00 | 0.875 | 1.85 | 3.76 | 8.42 | 4.99 | 6.16 | 0.481 | 0.7178 | 0.8641 | -- | 0.2547 | 13.92 | 9.92 | 5.30 | 1.28 | 1.51 | -5.34 | 5.92 |
Data as of Nov 13 2024. Currency figures normalised to ReproCell Inc's reporting currency: Japanese Yen JPY
1.19%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| SSgA Funds Management, Inc.as of 03 Oct 2024 | 614.00k | 0.65% |
| Simplex Asset Management Co., Ltd.as of 03 Oct 2024 | 504.90k | 0.54% |
| LGT Capital Partners AG (Investment Management)as of 31 May 2024 | 2.50k | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd.as of 31 Dec 2023 | 0.00 | 0.00% |
More ▼
Data from 30 Jun 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
